Simrat Randhawa - Net Worth and Insider Trading
Simrat Randhawa Net Worth
The estimated net worth of Simrat Randhawa is at least $86,800 dollars as of 2025-05-03. Simrat Randhawa is the Chief Medical Officer of Dianthus Therapeutics Inc and owns about 4,000 shares of Dianthus Therapeutics Inc (DNTH) stock worth over $86,800. Details can be seen in Simrat Randhawa's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Simrat Randhawa has not made any transactions after 2023-09-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Simrat Randhawa
Simrat Randhawa Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Simrat Randhawa owns 1 companies in total, including Magenta Therapeutics Inc (MGTA) .
Click here to see the complete history of Simrat Randhawa’s form 4 insider trades.
Insider Ownership Summary of Simrat Randhawa
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| MGTA | Magenta Therapeutics Inc | 2023-09-11 | Chief Medical Officer |
Simrat Randhawa Latest Holdings Summary
Simrat Randhawa currently owns a total of 1 stock. Simrat Randhawa owns 4,000 shares of Dianthus Therapeutics Inc (DNTH) as of September 22, 2023, with a value of $86,800.
Latest Holdings of Simrat Randhawa
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics Inc | 2023-09-22 | 4,000 | 21.70 | 86,800 |
Holding Weightings of Simrat Randhawa
Simrat Randhawa Form 4 Trading Tracker
According to the SEC Form 4 filings, Simrat Randhawa has made a total of 1 transactions in Dianthus Therapeutics Inc (DNTH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Dianthus Therapeutics Inc is the acquisition of 4,000 shares on September 22, 2023, which cost Simrat Randhawa around $52,800.
Insider Trading History of Simrat Randhawa
- 1
Simrat Randhawa Trading Performance
GuruFocus tracks the stock performance after each of Simrat Randhawa's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Simrat Randhawa is -14.63%. GuruFocus also compares Simrat Randhawa's trading performance to market benchmark return within the same time period. The performance of stocks bought by Simrat Randhawa within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Simrat Randhawa's insider trading performs compared to the benchmark.
Performance of Simrat Randhawa
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.24 | | | | | |
| Relative Return to S&P 500(%) | -5.02 | | | | | |
Simrat Randhawa Ownership Network
Ownership Network List of Simrat Randhawa
Ownership Network Relation of Simrat Randhawa
Simrat Randhawa Owned Company Details
What does Magenta Therapeutics Inc do?
Who are the key executives at Magenta Therapeutics Inc?
Simrat Randhawa is the Chief Medical Officer of Magenta Therapeutics Inc. Other key executives at Magenta Therapeutics Inc include director & 10 percent owner Peter Evan Harwin , director & 10 percent owner Tomas Kiselak , and director & 10 percent owner Fairmount Funds Management Llc .
Magenta Therapeutics Inc (MGTA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Magenta Therapeutics Inc Insider Transactions
Simrat Randhawa Mailing Address
Above is the net worth, insider trading, and ownership report for Simrat Randhawa. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Simrat Randhawa's mailing address is: New York Ny 10036.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
